Perfusion Medical, Inc. government contracts
$8.1M obligated across 4 federal awards. 2 are still running.
Who buys from Perfusion Medical, Inc.
| Agency | Awards | Obligated |
|---|---|---|
| Defense Health Agency | 2 | $4.5M |
| Department of the Air Force | 2 | $3.6M |
What Perfusion Medical, Inc. sells
Its awards by NAICS code. Codes with live notices link to them.
| Industry | Awards | Obligated |
|---|---|---|
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) NAICS 541715 | 4 | $8.1M |
Contracts ending soon
Awards that end in the next 18 months, soonest first. Expiring work is often recompeted.
| Award | Obligated | Start | End |
|---|---|---|---|
| HUMAN CLINICAL TRIAL FOR SAFETY OF PM-208 ANTI-SHOCK DRUG Department of the Air Force · FA864924P0531 | $1.8M | Jun 24, 2024 | Jan 26, 2027 |
| IND-ENABLING STUDIES OF PM-208: A NOVEL PRE-HOSPITAL ANTI-SHOCK THERAPEUTIC Defense Health Agency · HT942726CE025 | $1.5M | Apr 10, 2026 | Aug 9, 2027 |
Largest awards
By total obligated value. Each links to its record on USAspending.gov.
| Award | Obligated | Start | End |
|---|---|---|---|
| DHA SBIR DIRECT TO PHASE II MEDICAL R&D CONTRACT FROM PROPOSAL NO. H2D-0122 FOR "IND-ENABLING STUDIES OF PM-208: A NOVEL PRE-HOSPITAL ANTI-SHOCK THERAPEUTIC" Defense Health Agency · HT942523C0065 | $3M | Sep 15, 2023 | Jul 14, 2026 |
| HUMAN CLINICAL TRIAL FOR SAFETY OF PM-208 ANTI-SHOCK DRUG Department of the Air Force · FA864924P0531 | $1.8M | Jun 24, 2024 | Jan 26, 2027 |
| RESEARCH AND DEVELOPMENT OF OPTIMAL DOSING AND FORMULATION OF PM-208 (PEG-20K/8K) FOR AF FIELD USE Department of the Air Force · FA864924P0552 | $1.8M | Feb 9, 2024 | Apr 7, 2026 |
| IND-ENABLING STUDIES OF PM-208: A NOVEL PRE-HOSPITAL ANTI-SHOCK THERAPEUTIC Defense Health Agency · HT942726CE025 | $1.5M | Apr 10, 2026 | Aug 9, 2027 |
Similar contractors
Companies winning under the same main NAICS code.
| Contractor | Awards | Obligated |
|---|---|---|
| California Institute of Technology UEI YC1YP79BFD19 | 421 | $20.2B |
| The Aerospace Corporation UEI YA8LJBJCND19 | 75 | $9.4B |
| Lockheed Martin Corp UEI CQWLW9XRQTH5 | 15 | $8.3B |
| The Johns Hopkins University Applied Physics Laboratory LLC UEI C1HBCJ9RMBV3 | 795 | $7.7B |
| Lockheed Martin Corp UEI FYHNA5WC8XD7 | 13 | $7B |
| The Mitre Corporation UEI DMHDNDCPWUD1 | 214 | $6.3B |
Stop checking this page by hand
Matched, not listed
Describe your company once. Captivaq scores every new notice against your capabilities, locations, and set-asides.
Earlier than the RFP
Forecasts and sources sought notices surface months before the solicitation, while you can still shape the win.
A draft, not a link
For the bids worth pursuing, it reads the solicitation and drafts the response with citations back to the source.
Questions people ask
What is Perfusion Medical, Inc.'s UEI?
XEDJGXP1K889. The Unique Entity ID is the 12-character number SAM.gov assigns to every company that registers to do business with the federal government. It replaced the DUNS number in 2022.
How much has Perfusion Medical, Inc. won in federal contracts?
$8.1M obligated across 4 awards in Captivaq's records, most of it from Defense Health Agency. That covers contracts of $1M or more active since October 2023, so the full history is larger.
Which Perfusion Medical, Inc. contracts end soon?
2 awards end in the next 18 months, listed on this page. Expiring contracts are often recompeted, which is the opening for a competitor or a teaming partner.
Figures come from federal award records published on USAspending.gov: contracts of $1M or more active since October 2023, plus smaller awards tied to open opportunities. They are not a complete contract history; each award above links to its official record.
Captivaq is an independent service from Logesta Labs LLC and is not affiliated with or endorsed by the U.S. government or SAM.gov. The notice on the official source portal is the record that governs; confirm deadlines and amendments there.